SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (341)12/7/2002 8:28:05 PM
From: ewolf  Respond to of 508
 
OT Pardon me for the curiosity but how did you become afflicted with the crazy guy?



To: IRWIN JAMES FRANKEL who wrote (341)12/22/2002 1:05:17 PM
From: lrb  Read Replies (1) | Respond to of 508
 
As I recall, on the CC following the release of the trial results in late August, ITMN said they would know more about their plans for filing following a (Sept.?) meeting with the FDA. I don't recall hearing any more about this. Am I mis-remembering? Does anyone hear know when we should expect them to seek approval for Actimmune for IPF?


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News